VISTA Emerges as a Promising Immunotherapy Target in Cancer - Targeted Oncology

Describing the role of VISTA, an immunoregulatory molecule involved in maintaining T cell and myeloid quiescence, as a promising target in cancer immunotherapy.

VISTA, or V-domain immunoglobulin suppressor of T-cell activation, is an immunoregulatory molecule involved in maintaining T cell and myeloid quiescence.1 This review describes the role of VISTA as a… [+15257 chars]

full article...